D'Incalci M - Search Results

1

HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance.

Loria R, Laquintana V, Bon G, Trisciuoglio D, Frapolli R, Covello R, Amoreo CA, Ferraresi V, Zoccali C, Novello M, Del Bufalo D, Milella M, Biagini R, D'Incalci M, Falcioni R. Loria R, et al. Oncogene. 2018 Nov;37(45):5926-5938. doi: 10.1038/s41388-018-0394-x. Epub 2018 Jul 6. Oncogene. 2018. PMID: 29980789 Free PMC article.

2

High-performance liquid chromatographic assay for the determination of the novel taxane derivative IDN5109 in mouse plasma.

Colombo T, Frapolli R, Bombardelli E, Morazzoni P, Riva A, D'Incalci M, Zucchetti M. Colombo T, et al. J Chromatogr B Biomed Sci Appl. 1999 Dec 24;736(1-2):135-41. doi: 10.1016/s0378-4347(99)00450-8. J Chromatogr B Biomed Sci Appl. 1999. PMID: 10676993

3

High-performance liquid chromatographic assay for the determination of the novel C-Seco-taxane derivative (IDN 5390) in mouse plasma.

Zaffaroni M, Frapolli R, Colombo T, Fruscio R, Bombardelli E, Morazzoni P, Riva A, D'Incalci M, Zucchetti M. Zaffaroni M, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 15;780(1):93-8. doi: 10.1016/s1570-0232(02)00436-1. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 12383484

4

Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients.

Gambacorti-Passerini C, Zucchetti M, Russo D, Frapolli R, Verga M, Bungaro S, Tornaghi L, Rossi F, Pioltelli P, Pogliani E, Alberti D, Corneo G, D'Incalci M. Gambacorti-Passerini C, et al. Clin Cancer Res. 2003 Feb;9(2):625-32. Clin Cancer Res. 2003. PMID: 12576428 Clinical Trial.

5

Telomere dysfunction increases cisplatin and ecteinascidin-743 sensitivity of melanoma cells.

Biroccio A, Gabellini C, Amodei S, Benassi B, Del Bufalo D, Elli R, Antonelli A, D'Incalci M, Zupi G. Biroccio A, et al. Mol Pharmacol. 2003 Mar;63(3):632-8. doi: 10.1124/mol.63.3.632. Mol Pharmacol. 2003. PMID: 12606771

6

High-performance liquid chromatographic assay for the determination of Aloe Emodin in mouse plasma.

Zaffaroni M, Mucignat C, Pecere T, Zagotto G, Frapolli R, D'Incalci M, Zucchetti M. Zaffaroni M, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Oct 25;796(1):113-9. doi: 10.1016/j.jchromb.2003.08.012. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 14552822

7

Fetal bovine serum, but not human serum, inhibits the in vitro cytotoxicity of ET-743 (Yondelis, trabectedin), an example of potential problems for extrapolation of active drug concentrations from in vitro studies.

Tognon G, Frapolli R, Zaffaroni M, Erba E, Zucchetti M, Faircloth GT, D'Incalci M. Tognon G, et al. Cancer Chemother Pharmacol. 2004 Jan;53(1):89-90. doi: 10.1007/s00280-003-0704-y. Epub 2003 Oct 28. Cancer Chemother Pharmacol. 2004. PMID: 14586558 No abstract available.

8

Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients.

Fruscio R, Lissoni AA, Frapolli R, Corso S, Mangioni C, D'Incalci M, Zucchetti M. Fruscio R, et al. Cancer Chemother Pharmacol. 2006 Sep;58(3):319-25. doi: 10.1007/s00280-005-0160-y. Epub 2005 Dec 13. Cancer Chemother Pharmacol. 2006. PMID: 16362296 Clinical Trial.

9

Pharmacokinetics and metabolism in mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a new oral c-seco-taxane derivative with antiangiogenic property effective on paclitaxel-resistant tumors.

Frapolli R, Marangon E, Zaffaroni M, Colombo T, Falcioni C, Bagnati R, Simone M, D'Incalci M, Manzotti C, Fontana G, Morazzoni P, Zucchetti M. Frapolli R, et al. Drug Metab Dispos. 2006 Dec;34(12):2028-35. doi: 10.1124/dmd.106.012153. Epub 2006 Sep 8. Drug Metab Dispos. 2006. PMID: 16963486

10

G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors.

Leonetti C, Scarsella M, Riggio G, Rizzo A, Salvati E, D'Incalci M, Staszewsky L, Frapolli R, Stevens MF, Stoppacciaro A, Mottolese M, Antoniani B, Gilson E, Zupi G, Biroccio A. Leonetti C, et al. Clin Cancer Res. 2008 Nov 15;14(22):7284-91. doi: 10.1158/1078-0432.CCR-08-0941. Clin Cancer Res. 2008. PMID: 19010844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

560 results

Search Page